SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTPreferred Stock Purchase Agreement • May 6th, 2005 • Miravant Medical Technologies • Pharmaceutical preparations • Delaware
THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is entered into as of May 3, 2005, by and between MIRAVANT MEDICAL TECHNOLOGIES, a Delaware corporation (the "Company"), with headquarters located at 336 Bollay Drive, Santa Barbara, California 93117, and the purchasers (collectively, the "Purchasers" and each a "Purchaser") set forth on Schedule 1 hereof, with regard to the following:
EXHIBIT A TO SECURITIES PURCHASE AGREEMENT FORM OF WARRANTSecurities Purchase Agreement • May 6th, 2005 • Miravant Medical Technologies • Pharmaceutical preparations • California
NEITHER THIS WARRANT NOR ANY SHARES OF COMMON STOCK ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “SECURITIES ACT”). THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE OFFERED, SOLD, OR OTHERWISE TRANSFERRED IN THE ABSENCE OF REGISTRATION UNDER THE SECURITIES ACT OR UNLESS SUCH OFFER, SALE OR TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
EXHIBIT D TO SERIES B PREFERRED STOCK PURCHASE AGREEMENT REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 6th, 2005 • Miravant Medical Technologies • Pharmaceutical preparations • California
THIS REGISTRATION RIGHTS AGREEMENT, is entered into as of May 3, 2005, by and between MIRAVANT MEDICAL TECHNOLOGIES, a Delaware corporation (the “Company”), with headquarters located at 336 Bollay Drive, Santa Barbara, California 93117, and SCORPION CAPITAL PARTNERS, LP, ALBA LTD. and ALERT INVESTMENTS LIMITED (the “Purchasers”). Capitalized terms used herein are used as defined in Section 1 of this Agreement.
